These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 25204840)
21. Intraoperative use of recombinant activated factor VII (rFVIIa). De Gasperi A Minerva Anestesiol; 2006 Jun; 72(6):489-94. PubMed ID: 16682921 [TBL] [Abstract][Full Text] [Related]
22. Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency. Tcheng WY; Donkin J; Konzal S; Wong WY Haemophilia; 2004 May; 10(3):295-8. PubMed ID: 15086331 [TBL] [Abstract][Full Text] [Related]
23. Use of recombinant activated factor VII (rFVIIa-NovoSeven) in the treatment of uncontrolled postsurgical hemorrhage in a patient with deep venous thrombosis and caval filter. A case report. Marson F; Farnia A; Callegher L; Casagrande L; Surdu M; Sarpellon M Minerva Anestesiol; 2006; 72(7-8):675-82. PubMed ID: 16865086 [TBL] [Abstract][Full Text] [Related]
24. A rare combination: congenital factor VII deficiency with Chiari malformation. Bay A; Aktekin E; Erkutlu I Blood Coagul Fibrinolysis; 2015 Dec; 26(8):946-8. PubMed ID: 26248161 [TBL] [Abstract][Full Text] [Related]
26. Increased volume of distribution for recombinant activated factor VII and longer plasma-derived factor VII half-life may explain their long lasting prophylactic effect. Mathijssen NC; Masereeuw R; Holme PA; van Kraaij MG; Laros-van Gorkom BA; Peyvandi F; van Heerde WL Thromb Res; 2013 Aug; 132(2):256-62. PubMed ID: 23834817 [TBL] [Abstract][Full Text] [Related]
27. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage. Le Roux P; Pollack CV; Milan M; Schaefer A J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496 [TBL] [Abstract][Full Text] [Related]
28. Effect of hemodilution on coagulation and recombinant factor VIIa efficacy in human blood in vitro. Darlington DN; Delgado AV; Kheirabadi BS; Fedyk CG; Scherer MR; Pusateri AE; Wade CE; Cap AP; Holcomb JB; Dubick MA J Trauma; 2011 Nov; 71(5):1152-63. PubMed ID: 21610535 [TBL] [Abstract][Full Text] [Related]
29. Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal. Mariani G; Konkle BA; Ingerslev J Haemophilia; 2006 Jan; 12(1):19-27. PubMed ID: 16409171 [TBL] [Abstract][Full Text] [Related]
30. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease. Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322 [TBL] [Abstract][Full Text] [Related]
32. Repeated recombinant activated factor VII administration in a patient with congenital factor VII deficiency undergoing modified radical hysterectomy: a case report. Shirasawa H; Yoshioka T; Sawada K; Terada Y Haemophilia; 2014 Jan; 20(1):e101-3. PubMed ID: 24261688 [No Abstract] [Full Text] [Related]
33. Recombinant factor VIIa treatment for asymptomatic factor VII deficient patients going through major surgery. Livnat T; Shenkman B; Spectre G; Tamarin I; Dardik R; Israeli A; Rivkind A; Shabtai M; Marinowitz U; Salomon O Blood Coagul Fibrinolysis; 2012 Jul; 23(5):379-87. PubMed ID: 22527290 [TBL] [Abstract][Full Text] [Related]
34. Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery. Rao VK; Lobato RL; Bartlett B; Klanjac M; Mora-Mangano CT; Soran PD; Oakes DA; Hill CC; van der Starre PJ J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1221-6. PubMed ID: 25281040 [TBL] [Abstract][Full Text] [Related]
35. Recombinant factor VIIa reduces bleeding risk in patients on platelet aggregation inhibitors immediately prior to renal transplantation--a retrospective analysis. Loertzer H; Soukup J; Fornara P Urol Int; 2007; 78(2):135-9. PubMed ID: 17293653 [TBL] [Abstract][Full Text] [Related]
36. Safe use of recombinant activated factor VIIa for recalcitrant postoperative haemorrhage in cardiac surgery. Tatoulis J; Theodore S; Meswani M; Wynne R; Hon-Yap C; Powar N Interact Cardiovasc Thorac Surg; 2009 Sep; 9(3):459-62. PubMed ID: 19542087 [TBL] [Abstract][Full Text] [Related]
37. Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. Guzzetta NA; Huch S; Fernandez JD; Tosone SR; Miller BE Paediatr Anaesth; 2009 Apr; 19(4):364-70. PubMed ID: 19143947 [TBL] [Abstract][Full Text] [Related]
38. Successful use of recombinant VIIa (Novoseven) and endometrial ablation in a patient with intractable menorrhagia secondary to FVII deficiency. White B; O'Connor H; Smith OP Blood Coagul Fibrinolysis; 2000 Mar; 11(2):155-7. PubMed ID: 10759008 [TBL] [Abstract][Full Text] [Related]
39. [Our experience with recombinant activated factor VII (NovoSeven) in the high risk cardiosurgical patients with bleeding complication]. Miskolczi S; Vaszily M; Papp C; Péterffy A Magy Seb; 2008; 61 Suppl():45-7. PubMed ID: 18504237 [TBL] [Abstract][Full Text] [Related]
40. Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors. Giangrande PL; Wilde JT; Madan B; Ludlam CA; Tuddenham EG; Goddard NJ; Dolan G; Ingerslev J Haemophilia; 2009 Mar; 15(2):501-8. PubMed ID: 19187194 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]